Table 2.

Univariable Analysis of Relapse

VariableRelative Risk95% CIP Value
 
PCR status 
Negative 1.0 
p190 or p210+ 5.7 1.2-26.0 .025 
PCR status 
Negative 1.0 
p190+ 11.2 2.3-54.8 .003 
Donor type 
Auto, twin, Rel= 1.0 
URD, Rel-mm 0.4 0.1-1.4 .133 
Acute GVHD 
Grades 0-1 1.0 
Grades 2-4 0.6 0.2-2.0 .427 
Phase of disease 
Remission 1.0 
Relapse 2.6 0.8-8.3 .106 
Conditioning 
TBI > 1,200 cGY 1.0 
Chemo only or <1,200 cGy 4.6 1.5-14.5 .008 
VariableRelative Risk95% CIP Value
 
PCR status 
Negative 1.0 
p190 or p210+ 5.7 1.2-26.0 .025 
PCR status 
Negative 1.0 
p190+ 11.2 2.3-54.8 .003 
Donor type 
Auto, twin, Rel= 1.0 
URD, Rel-mm 0.4 0.1-1.4 .133 
Acute GVHD 
Grades 0-1 1.0 
Grades 2-4 0.6 0.2-2.0 .427 
Phase of disease 
Remission 1.0 
Relapse 2.6 0.8-8.3 .106 
Conditioning 
TBI > 1,200 cGY 1.0 
Chemo only or <1,200 cGy 4.6 1.5-14.5 .008 

Univariable analysis of the relative risk of relapse associated with PCR status, donor type, acute and chronic GVHD, remission status at the time of transplant, and type of conditioning regimen. In the chronic GVHD category, “positive” means clinically extensive disease.

Close Modal

or Create an Account

Close Modal
Close Modal